Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Balasch, J.
Right arrow Articles by Arroyo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasch, J.
Right arrow Articles by Arroyo, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 13, No. 10, 2718-2730, October 1998
© 1998 European Society of Human Reproduction and Embryology

Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome

Juan Balasch1, Francisco Fábregues1 and Vicente Arroyo2

1 Department of Obstetrics and Gynecology, Hospital Clinic i Provincial-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 2 Liver Unit, Institut Clinic of Digestive Disease, Department of Medicine, Faculty of Medicine-University of Barcelona, Hospital Clinic i Provincial-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Correspondence: To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Hospital Clinic i Provincial, C/Casanova 143, 08036-Barcelona, Spain

Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ovulation induction which, at present, is being studied increasingly because of its frequent occurrence as a result of the growing number of in-vitro fertilization (IVF) programmes. The anatomical changes involving enlargement of the ovaries and increased capillary permeability leading to acute fluid shift have been traditionally proposed to explain the different clinical features observed in OHSS. Recent work from our group, however, has shown that the pathogenesis of severe OHSS is more complex than currently understood and that marked peripheral arteriolar vasodilation is a major event in the development of the syndrome. Peripheral vasodilation may, in its turn, alter microvascular haemodynamics and permeability. This leads to a circulatory dysfunction with marked homeostatic activation of endogenous vasoactive systems having vasoconstrictor and sodium- and water-retaining activities. In this way, sodium and water retention would be a cause rather than a consequence of ascites formation in severe OHSS. This report analyses current concepts on body fluid regulations as well as neurohormonal and haemodynamic studies both in patients with severe OHSS and asymptomatic IVF women, integrating their findings into the present knowledge of the pathogenesis of the syndrome. Therapeutic implications are discussed.

Key words: IVF/ovarian hyperstimulation syndrome/peripheral vasodilation/renin/sodium retention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Villasante, A. Pacheco, E. Pau, A. Ruiz, A. Pellicer, and J.A. Garcia-Velasco
Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome
Hum. Reprod., March 1, 2008; 23(3): 662 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Villasante, A. Pacheco, A. Ruiz, A. Pellicer, and J. A. Garcia-Velasco
Vascular Endothelial Cadherin Regulates Vascular Permeability: Implications for Ovarian Hyperstimulation Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 314 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. C. Ajonuma, L. L. Tsang, G. H. Zhang, C. H. Y. Wong, M. C. Lau, L. S. Ho, D. K. Rowlands, C. X. Zhou, C. P. Ng, J. Chen, et al.
Estrogen-Induced Abnormally High Cystic Fibrosis Transmembrane Conductance Regulator Expression Results in Ovarian Hyperstimulation Syndrome
Mol. Endocrinol., December 1, 2005; 19(12): 3038 - 3044.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Bellver, E. Escudero, and A. Pellicer
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): Ovarian mutilating surgery is not an option in the management of severe OHSS
Hum. Reprod., July 1, 2003; 18(7): 1363 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. Gomez, C. Simon, J. Remohi, and A. Pellicer
Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability
Biol Reprod, June 1, 2003; 68(6): 2164 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Z.O. Amarin
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome: An aggressive, but perhaps life-saving procedure
Hum. Reprod., April 1, 2003; 18(4): 659 - 664.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Sasson and A. Amsterdam
Stimulation of Apoptosis in Human Granulosa Cells from in Vitro Fertilization Patients and Its Prevention by Dexamethasone: Involvement of Cell Contact and Bcl-2 Expression
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3441 - 3451.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Ekerhovd, A. Enskog, K. Caidahl, N. Klintland, L. Nilsson, M. Brannstrom, and A. Norstrom
Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome
Hum. Reprod., July 1, 2001; 16(7): 1334 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C.-D. Chen, M.-Y. Wu, H.-F. Chen, S.-U. Chen, H.-N. Ho, and Y.-S. Yang
Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome
Hum. Reprod., January 1, 2000; 15(1): 66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A.P. Murdoch and I. Evbuomwan
Severe complications of ovarian hyperstimulation syndrome are preventable
Hum. Reprod., November 1, 1999; 14(11): 2922 - 2924.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Al-Ramahi
Severe OHSS: Decreasing the risk of severe ovarian hyperstimulation syndrome
Hum. Reprod., October 1, 1999; 14(10): 2421 - 2422.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Todros, C.M. Carmazzi, S. Bontempo, P. Gaglioti, V. Donvito, and M. Massobrio
Spontaneous ovarian hyperstimulation syndrome and deep vein thrombosis in pregnancy: Case report
Hum. Reprod., September 1, 1999; 14(9): 2245 - 2248.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D.Y. Midgley, Y. Khalaf, P.R. Braude, and C. Nelson-Piercy
Recurrent cholestasis following ovarian hyperstimulation syndrome: Case report
Hum. Reprod., September 1, 1999; 14(9): 2249 - 2251.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.